SEC Form 4
The Pennant Group, Inc. (PNTG) insider trading
In the 12 months to Oct 26, 2026, 3 PNTG insiders reported open-market sales of $690.1K across 6 filings; no open-market purchases were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $690.1K
- 6 filings · 3 insiders
- Open-market purchases
- $0
- 0 filings
- Pre-arranged sales (10b5-1)
- 4 of 6
- $471.4K of $690.1K sold (68%)
Who traded PNTG, and when
- Sale
- Sale, pre-arranged (10b5-1)
PNTG daily close from Oct 27, 2025 to Oct 26, 2026, between $23.75 and $42.60, last $42.60. 6 sale and 0 purchase filings by 3 insiders, marked at their filing dates. Brent Guerisoli, Chief Executive Officer: sold $582.7K across 4 filings, first filed May 27, 2026, last Aug 10, 2026. Jason Paul Steik, Chief Clinical Officer: sold $53.7K across 1 filing, first filed Aug 10, 2026, last Aug 10, 2026. Kirk Sterling Cheney, EVP, GC and Corp Secy: sold $53.7K across 1 filing, first filed Aug 10, 2026, last Aug 10, 2026.
Largest mark · tap a row for others
Brent Guerisoli · Chief Executive Officer
Filing 1 of 2 within a week · $259,518 total
Sale $128,214
3,165 shares at $40.51 avg
Filed Jul 9, 2026 · traded Jul 7
Pre-arranged (10b5-1) · close on filing date $40.46
Brent Guerisoli · Chief Executive Officer
Chief Executive Officer
$582.7K soldJason Paul Steik · Chief Clinical Officer
Chief Clinical Officer
$53.7K soldKirk Sterling Cheney · EVP, GC and Corp Secy
EVP, GC and Corp Secy
$53.7K soldOpen-market trades
6 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Brent Guerisoli | Chief Executive Officer | $582.7K | — | 4 | 72% of sales | |
| Jason Paul Steik | Chief Clinical Officer | $53.7K | — | 1 | 100% of sales | |
| Kirk Sterling Cheney | EVP, GC and Corp Secy | $53.7K | — | 1 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Kirk Sterling Cheney EVP, GC and Corp Secy | Sale | 1,393 | $38.52 | $53.7K | 18,401 | |
traded | Brent Guerisoli Chief Executive Officer | Sale | 4,285 | $38.52 | $165.1K | 99,544 | |
traded | Jason Paul Steik Chief Clinical Officer | SalePre-arranged (10b5-1) | 1,394 | $38.52 | $53.7K | 15,106 | |
traded | Brent Guerisoli Chief Executive Officer | SalePre-arranged (10b5-1) | 3,159 | $41.57 | $131.3K | 103,829 | |
traded | Brent Guerisoli Chief Executive Officer | SalePre-arranged (10b5-1) | 3,165 | $40.51 | $128.2K | 100,740 | |
traded | Brent Guerisoli Chief Executive Officer | SalePre-arranged (10b5-1) | 4,508 | $35.08 | $158.1K | 97,679 |
GET /stocks/filings/vX/form-4?tickers=PNTG&filing_date.gte=2025-10-26&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"PNTG"
],
"issuer_cik": "0001766400",
"owner_cik": "0001838360",
"accession_number": "0001838360-26-000007",
"form_type": "4",
"filing_date": "2026-08-10",
"period_of_report": "2026-08-06",
"issuer_name": "Pennant Group, Inc.",
"issuer_trading_symbol": "PNTG",
"owner_name": "Guerisoli Brent",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "Chief Executive Officer",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-08-06",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 4285,
"transaction_price_per_share": 38.522,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 99544,
"transaction_value": 165066.77,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024"
}
]
},
{
"tickers": [
"PNTG"
],
"issuer_cik": "0001766400",
"owner_cik": "0002080298",
"accession_number": "0001766400-26-000067",
"form_type": "4",
"filing_date": "2026-08-10",
"period_of_report": "2026-08-06",
"issuer_name": "Pennant Group, Inc.",
"issuer_trading_symbol": "PNTG",
"owner_name": "Cheney Kirk Sterling",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "EVP, GC and Corp Secy",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-08-06",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 1393,
"transaction_price_per_share": 38.522,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 18401,
"transaction_value": 53661.146,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on August 26, 2022"
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 37 records
- Option exercises5 records
- Grants and awards32 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Pre-arranged (10b5-1)
- The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
Has The Pennant Group, Inc.'s CEO sold stock?
Yes. Brent Guerisoli (CEO) sold 15,117 shares ($582.7K) between May 2026 and Aug 2026, $417.7K of it under a pre-arranged 10b5-1 plan.
How current is PNTG’s insider data?
These are PNTG Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track PNTG insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for PNTG every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.